Serial Number
77813531
Owner
Saint Joseph's UniversityAttorney
Christopher D. Olszyk, Jr.First Use Date
Jul 1, 1998
Filing Date
Aug 26, 2009
UNIVERSITY OF THE SCIENCES Trademark
Serial Number: 77813531 • Registration: 4175968
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
600 South 43rd Street
Philadelphia, PA 19104
Entity Type: 99
Legal Representation
Trademark Details
Filing Date
August 26, 2009
Registration Date
July 17, 2012
First Use Anywhere
July 1, 1998
First Use in Commerce
July 1, 1998
Published for Opposition
September 6, 2011
Goods & Services
Educational services, namely, providing courses of instruction at the undergraduate, graduate, and post-graduate levels; providing educational research programs for all aspects of pharmaceutical study; providing continuing education conferences, seminars and workshops in the fields of pharmaceutical study, health care, and health sciences; conducting educational conferences and seminars in the fields of the study of pharmacy and the pharmaceutical and health care industries; publication of newsletters, news briefs, and monographs for pharmacists and health care professionals [ ; entertainment services in the nature of presentation of a variety of intercollegiate sporting events, namely, cross-country, cheerleading, rifle, basketball, baseball, golf, tennis, softball, and volleyball ]
[ Providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, research about patient reimbursement for pharmaceuticals and financing the research of others in the field of pharmacoeconomics; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, financing the research of others ]
[ Business consulting services for the pharmaceutical and health care industries, namely, pharmaceutical care management programs in the nature of cost management and drug utilization review for pharmaceutical benefit plans for private and public agencies, organizations, institutions, and individuals; Business research services, namely, providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy utilization and costs reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly, namely, drug utilization review research for the pharmaceutical and health care industries ]
[ Technical consulting services in the nature of pharmaceutical technology consulting for pharmaceutical care management programs provided to private and public agencies, organizations, institutions, and individuals for the pharmaceutical and health care industries; Research consulting services in the nature of pharmaceutical research services for pharmaceutical care management programs for private and public agencies, organizations, institutions, and individuals in the pharmaceutical and health care industries; providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy selection, utilization, costs, and reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, pharmaceutical research services; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, research in the field of pharmaceuticals ]